Fluidigm Corp
NASDAQ:FLDM
Fluidigm Corp
NASDAQ:FLDM
Price:
3.71 USD
-7.02%
Market Closed
Updated:
Apr 29, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of FLDM.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
FLDM
Relative Value
Base Case
Not Available
Valuation Multiples
Multiples Across Competitors
FLDM Competitors Multiples
Fluidigm Corp Competitors
Fluidigm Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Fluidigm Corp
NASDAQ:FLDM
|
285.4m USD | 2.2 | -4.8 | -6.2 | -4.8 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.8B USD | 5.2 | 37 | 22.8 | 33.5 | |
| US |
|
Danaher Corp
NYSE:DHR
|
182.6B USD | 4.2 | 22.6 | 16.5 | 20.3 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
42.6B USD | 2.8 | 31.4 | 17 | 26.2 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
38.1B CHF | 5.7 | 58.2 | 20 | 29.3 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
40.4B USD | 6 | 32.7 | 26.1 | 31.4 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
54.9T KRW | 14.9 | 64.1 | 33.7 | 48.6 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.7B USD | 7 | 33.8 | 23.6 | 26.3 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.5B USD | 9 | 44.6 | 30.5 | 36.5 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
25.4B USD | 3.1 | 41.5 | 17.6 | 27.5 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
19.2B EUR | 7.1 | 75.4 | 32.4 | 53.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
